Activist shareholder attempts to scupper AMO Bausch & Lomb bid

Warburg Pincus’ bid for Bausch & Lomb looked more likely, as trade buyer Advanced Medical Optics’ third largest shareholder ValueAct Capital criticised the risk involved in the healthcare company’s higher counter bid.

Share this